Herpes zoster incidence in diabetic patients
Keywords:
Herpes zóster. Diabetes mellitus. Virus varicela-zóster. Incidencia. España.Abstract
Objective: To assess the risk of herpes zoster in people with diabetes mellitus in comparison with the general population. Methods: Using computerized clinical reports form primary health care in Navarre, Spain we analyzed the incidence of herpes zoster in people over 30 years in 2006 by diagnosis of diabetes, and adjusting for age and sex. Results: Among 26,793 diabetes patients 409 cases of herpes zoster were diagnosed (15 per 1000). 19.3% of cases occurred in diabetes patients. Diabetes presented an adjusted relative risk of 2.1 (95% IC 1.9-2.4), and the 30-44 years age-group increased to 3.7 (95% IC 2.0-6.8). Of the total number of cases of herpes zoster in the papulation, 7.2% were attributable to diabetes. Conclusion: Diabetes increases the risk and has a relevant role in the incidence of herpes zoster.Downloads
References
1. MUELLER NH, GILDEN DH, COHRS RJ, MAHALINGAM R, NAGEL MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin 2008; 26: 675-697.
https://doi.org/10.1016/j.ncl.2008.03.011
2. CEBRIAN-CUENCA AM, DÍEZ-DOMINGO J, SAN MARTÍN M, PUIG-BARBERÁ J, NAVARRO-PÉREZ J. Epidemiology of herpes zoster infection among patients treated in primary care centres in Valencian Community (Spain). BMC Fam Pract 2010; 6: 11-33.
https://doi.org/10.1186/1471-2296-11-33
3. GARCÍA CENOZ M, CASTILLA J, MONTES Y, MORÁN J, SALABERRI A, ELÍA F et al. Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005-2006. An Sist Sanit Navar 2008; 31: 71-80.
https://doi.org/10.4321/S1137-66272008000100006
4. REYNOLDS MA, CHAVES SS, HARPAZ R, LOPEZ AS, SEWARD JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197: S224-227.
https://doi.org/10.1086/522162
5. NASSAJI-ZAVAREH M, TAHERI R, GHORBANI R, AMINIAN M. Undiagnosed diabetes mellitus in patients with Herpes Zoster. Indian J Dermatol 2008; 53: 119-121.
https://doi.org/10.4103/0019-5154.43211
6. OXMAN MN, LEVIN MJ, JOHNSON GR, SCHMADER KE, STRAUS SE, GELB LD et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-2284.
https://doi.org/10.1056/NEJMoa051016
7. GIL A, SAN-MARTÍN M, CARRASCO P, GONZÁLEZ A. Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine 2004; 22: 3947-3951.
https://doi.org/10.1016/j.vaccine.2004.04.004
8. OXMAN MN. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence. J Am Osteopath Assoc 2009; 109: S13-17.
9. OPSTELTEN W, VAN ESSEN GA, SCHELLEVIS F, VERHEIJ TJ, MOONS KG. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006; 16: 692-695.
https://doi.org/10.1016/j.annepidem.2005.12.002
10. OKAMOTO S, HATA A, SADAOKA K, YAMANISHI K, MORI Y. Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis 2009; 200: 1606-1610.
https://doi.org/10.1086/644646
11. HEYMANN AD, CHODICK G, KARPATI T, KAMER L, KREMER E, GREEN MS et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection 2008; 36: 226-230.
https://doi.org/10.1007/s15010-007-6347-x
12. JIH JS, CHEN YJ, LIN MW, CHEN YC, CHEN TJ, HUANG YL et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol 2009; 89: 612-616.
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
